Advancing Personalized Cancer Care

New AI Predicts Cancer Spread with 80% Accuracy

University of Geneva researchers develop MangroveGS to identify risks of metastasis and recurrence.

By Avantgarde News Desk··1 min read
A scientist reviews genetic data on a digital display using AI to predict cancer metastasis risks.

A scientist reviews genetic data on a digital display using AI to predict cancer metastasis risks.

Photo: Avantgarde News

Researchers at the University of Geneva have developed MangroveGS, a new artificial intelligence tool designed to predict cancer spread [1]. The system analyzes gene expression patterns to assess the likelihood of metastasis and recurrence [1]. Results show the tool achieves nearly 80% accuracy across multiple cancer types [1]. MangroveGS identifies specific biological signatures that signal whether a tumor will return or migrate [1]. This innovation aims to help doctors tailor individual treatment plans more effectively [1]. The study highlights the tool's consistent performance across various diverse patient profiles [1].

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

High

The risk level is set to high because the provided source list contains only one domain, which fails the requirement for at least three independent domains to verify scientific claims.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers advancing personalized cancer care and editorial analysis for Avantgarde News.